Indication
Lung Transplant Failure and Rejection
2 clinical trials
2 products
Product
Liposomal Cyclosporine AClinical trial
A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Single Lung TransplantStatus: Active (not recruiting), Estimated PCD: 2024-04-05
Clinical trial
A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Double Lung TransplantStatus: Active (not recruiting), Estimated PCD: 2024-04-05
Product
Standard of Care